Loading...
Loading...
International Journal of Public Health and Pharmacology
Vol. 5Issue 22025pp. 75–87Published 27 October 2025
DOI 10.52589/IJPHP-UMHXM0ONShare Link
Cite this
Citation unavailable for this article.
Abstract:
Hydroquinone (1,4-dihydroxybenzene) is a chemical substance with widespread uses in cosmetics, industry, and medicine as a skin-lightening agent and antioxidant. In this article, the chemical nature of hydroquinone, metabolic transformations involved, and toxicological significance, with emphasis on its renal impact have been addressed. Even though hydroquinone is anti-hyperpigmentary and anti-melasmic, it has significant risks due to its ability to cause oxidative stress, nephrotoxicity, and systemic toxicity after prolonged exposure. The medication is metabolized into reactive metabolites with the ability to damage renal tissues and disrupt cellular redox homeostasis. Chronic exposure, especially via unregulated cosmeceuticals, increases the likelihood of adverse health effects like kidney damage, exogenous ochronosis, and carcinogenicity. Hydroquinone product prevalence in locales of elevated skin lightening demand—is fueled by sociocultural constructions of beauty—underscores the need for greater regulatory oversight and education. This article emphasizes the importance of cosmetovigilance as a public health approach and endorses global regulatory measures to minimize the risks in the application of hydroquinone while ensuring consumer safety.
Disclaimer/Publisher’s Note
The statements, opinions and data contained in this publication are solely those of the author(s) and contributor(s) and not of AB Journals or its editors. AB Journals remains neutral and accepts no responsibility for any injury or damage resulting from ideas, methods, instructions or products referred to in the content.
Copyrights